These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22440152)

  • 1. Methotrexate in psoriasis: do we need to give a test dose?
    Carretero-Hernández G
    Actas Dermosifiliogr; 2012 Jan; 103(1):1-4. PubMed ID: 22440152
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review.
    Prey S; Paul C
    Br J Dermatol; 2009 Mar; 160(3):622-8. PubMed ID: 18945303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
    Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS
    J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate Dosing Regimen for Plaque-type Psoriasis: A Systematic Review of the Use of Test-dose, Start-dose, Dosing Scheme, Dose Adjustments, Maximum Dose and Folic Acid Supplementation.
    Menting SP; Dekker PM; Limpens J; Hooft L; Spuls PI
    Acta Derm Venereol; 2016 Jan; 96(1):23-8. PubMed ID: 25721372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Eventration and methotrexate in psoriasis].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2010 Oct; 137(10):672. PubMed ID: 20932456
    [No Abstract]   [Full Text] [Related]  

  • 6. Folate supplementation during methotrexate therapy for patients with psoriasis.
    Strober BE; Menon K
    J Am Acad Dermatol; 2005 Oct; 53(4):652-9. PubMed ID: 16198787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prescription and surveillance of treatment by a systemic agent or biotherapy in psoriasis].
    Boulinguez S
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):8-12. PubMed ID: 20510169
    [No Abstract]   [Full Text] [Related]  

  • 8. [Extensive erosive hemorrhagic lesions in psoriasis plaques caused by methotrexate poisoning].
    Rytter M; Haustein UF
    Dermatol Monatsschr; 1989; 175(1):55-8. PubMed ID: 2522069
    [No Abstract]   [Full Text] [Related]  

  • 9. Local reaction after subcutaneous injection of methotrexate: uncommon side effect.
    Priego-Recio CM; Camacho-Martínez FM
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):523-4. PubMed ID: 25546179
    [No Abstract]   [Full Text] [Related]  

  • 10. Excessive drowsiness with low-dose methotrexate.
    Handa S; Saraswat A; Kaur I; Kumar B
    Int J Dermatol; 2004 Sep; 43(9):701-2. PubMed ID: 15357759
    [No Abstract]   [Full Text] [Related]  

  • 11. Parenteral methotrexate in psoriasis. A report on the efficacy and toxicity of long-term intermittent treatment.
    McDonald CJ; Bertino JR
    Arch Dermatol; 1969 Dec; 100(6):655-68. PubMed ID: 4243752
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxicity of low dose methotrexate in rheumatoid arthritis.
    Weinblatt ME
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():35-9. PubMed ID: 3913775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation of methotrexate in psoriasis.
    Due E; Blomberg M; Skov L; Zachariae C
    Acta Derm Venereol; 2012 Jul; 92(4):353-4. PubMed ID: 22001863
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug therapy: immunosuppressive agents (second of two parts).
    Kaplan SR; Calabresi P
    N Engl J Med; 1973 Dec; 289(23):1234-6. PubMed ID: 4594161
    [No Abstract]   [Full Text] [Related]  

  • 15. [Methotrexate-induced pneumonitis in a woman with Crohn's disease].
    Brechmann T; Heyer C; Schmiegel W
    Dtsch Med Wochenschr; 2007 Aug; 132(34-35):1759-62. PubMed ID: 17713885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and methotrexate therapy for psoriasis.
    Hughes R; Harries M; Chalmers RJ; Kirby B
    J Am Acad Dermatol; 2006 Aug; 55(2):366-7. PubMed ID: 16844540
    [No Abstract]   [Full Text] [Related]  

  • 17. Methotrexate pneumonitis precipitated by switching from oral to parenteral administration.
    Collins K; Aspey H; Todd A; Saravanan V; Rynne M; Kelly C
    Rheumatology (Oxford); 2008 Jan; 47(1):109-10. PubMed ID: 18042567
    [No Abstract]   [Full Text] [Related]  

  • 18. Focal skin toxicity related to methotrexate sparing psoriatic plaques.
    Truchuelo T; Alcántara J; Moreno C; Vano-Galván S; Jaén P
    Dermatol Online J; 2010 Jun; 16(6):16. PubMed ID: 20579471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methotrexate in the therapy of psoriasis].
    Stáva Z
    Cesk Dermatol; 1973 Jun; 48(3):203-6. PubMed ID: 4725888
    [No Abstract]   [Full Text] [Related]  

  • 20. Methotrexate for psoriasis: current European practice. A postal survey.
    Boffa MJ
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):196-202. PubMed ID: 15752290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.